ArticleBlood neoplasia2026

Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium report.

Eric S Schafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.